A Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry Eye

Clinical trial NCT01960010 · COMPLETED

Trial details

NCT number: NCT01960010
Sponsor: Mimetogen Pharmaceuticals USA, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Dry Eye Syndromes

Start date: 2013-10-01
Primary completion: 2014-08-01
Enrollment: 403

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.